← Leaderboards
Scott Michael Damrauer
University Of Pennsylvania
$2,419,569
Attributed
$3,401,632
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,401,632 · 3
VA$0 · 2
By mechanism
R01$3,401,632 · 3
I01$0 · 1
IK2$0 · 1
Top collaborators
- Thomas P Cappola1 shared
- Hong Shen Lu1 shared
- Ryan Eugene Temel1 shared
- Xiao Wang1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Thomas A. Wadden$34,016,838
- Kiran Musunuru$21,648,838
- Daniel James Rader$77,348,993
- Marina Cuchel$7,792,390
- Aaron Robert Goldman$1,293,622
Others in their field
Other Emerging Leaders on “Genome Wide Association Study”
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,188,684
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
- Badri N Vardarajan · University Of Miami School Of Medicine$13,093,039
- Kim Doheny · Johns Hopkins University$11,742,549
- Leonard Freedmand · Leidos Biomedical Research, Inc.$11,639,100
Research focus
Genome Wide Association StudyGeneticPreventAffectPharmaceutical PreparationsGenomicsPrecision MedicineHeartRisk FactorsLipidsCessation Of LifeTraitBlood PressureCardiovascular Disorder RiskCerebrovascular DisordersIschemic StrokeMorbidity - Disease RateArteriesCardiovascular DiseasesElectronic Health RecordGenetic RiskHigh RiskDesignAlgorithms
Grant awards (14)
MTSS1 in myocardial disease$759,712
R01 · FY2025 · HL
Triglyceride-rich lipoproteins and abdominal aortic aneurysm growth and progression$713,382
R01 · FY2025 · HL · contact PI
Impact of PCSK9 inhibition on abdominal aortic aneurysm pathobiology and growth$675,678
R01 · FY2025 · HL · contact PI
Leveraging the Genetics of carotid stenosis for identifying novel risk factors and therapeutic opportunities$0
I01 · FY2025 · VA · contact PI
Impact of PCSK9 inhibition on abdominal aortic aneurysm pathobiology and growth$589,331
R01 · FY2024 · HL · contact PI
Leveraging the Genetics of carotid stenosis for identifying novel risk factors and therapeutic opportunities$0
I01 · FY2024 · VA · contact PI
Impact of PCSK9 inhibition on abdominal aortic aneurysm pathobiology and growth$663,529
R01 · FY2023 · HL · contact PI
Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk Prediction$0
IK2 · FY2023 · VA · contact PI
Leveraging the Genetics of carotid stenosis for identifying novel risk factors and therapeutic opportunities$0
I01 · FY2023 · VA · contact PI
Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk Prediction$0
IK2 · FY2022 · VA · contact PI
Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk Prediction$0
IK2 · FY2021 · VA · contact PI
Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk Prediction$0
IK2 · FY2020 · VA · contact PI
Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk Prediction$0
IK2 · FY2019 · VA · contact PI
Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk Prediction$0
IK2 · FY2018 · VA · contact PI